Emeryville, United States
Berkeley Lights, founded in 2011, has positioned itself as a pioneering entity in the biopharma and biotechnology sectors. Based in the United States, the company leverages its cutting-edge technology to accelerate the rapid development and commercialization of biotherapeutics and cell-based products. With the slogan "Accelerate your path to live cell function and recovery," Berkeley Lights is committed to advancing functional cell biology.
The company offers the Berkeley Lights Platform, which captures comprehensive data on single cells, aiding researchers in uncovering deep phenotypic and genotypic insights at scale. Their proprietary tools, including OptoSelect™ chips and advanced automation systems, are fully integrated to enhance the cell-based product development process.
The Beacon® and Lightning™ systems, alongside the Culture Station™ instrument, are designed for research use, emphasizing their focus on innovation within non-diagnostic processes. These solutions position Berkeley Lights as a potential industry standard in an evolving market. The company has not disclosed its latest investments or supporting investors, which signals a potential opportunity for new venture capital relationships and strategic growth financing.
